Ads
related to: car t-cell therapy- About Therapy
Learn About MOA And How
Therapy Works.
- Manufacturing
Learn More About
Manufacturing Process.
- Find Support
Find Patient Enrollment
& Reimbursement Support.
- Prescribing Information
Find Prescribing Info
And Medication Guide.
- Efficacy Information
Read The Study Design
And Efficacy Results.
- Safety Information
Review Clinical Data
And Adverse Reactions
- About Therapy
Search results
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 5 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 6 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread beyond the prostate and no longer responded ...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 6 days agoOncological researchers suspect that disappointing treatment results can be the result of several circumstances, including poor quality of the CAR-T < ...
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 14 hours agoHe also highlighted that overall, there are 1,023 single country adoptive cell therapy clinical studies being run in the APAC region compared to 476 in...
ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy
BioPharma-Reporter· 7 days agoThe US firm AffyImmune Therapeutics discusses how its donor cell-derived candidate could address...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 17 hours agoT cell immunotherapies. The agency said it had determined that the risk of T-cell malignancies was...
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 14 hours agoThe recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell ...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 6 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 5 days agoNew research provides insight into ultra-rare case of secondary cancer in a patient who received CAR...
Ads
related to: car t-cell therapy
